特异性-话题@MedSci

#特异性#

563篇内容 | 2153人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1899555, encodeId=51231899555be, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=双特异性抗体中CrossMab技术：过去的10年, objectType=article, longId=727173, objectId=f691e2717303, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f691e2717303, replyNumber=0, likeNumber=77, createdTime=2022-11-15, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f691e2717303, moduleTitle=双特异性抗体中CrossMab技术：过去的10年, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f691e2717303)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899505, encodeId=0a72189950547, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Nat Med：靶向CD19和CD22的双特异性CAR-T疗法可治疗复发性/难治性B细胞恶性肿瘤, objectType=article, longId=214948, objectId=920821494873, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=920821494873, replyNumber=0, likeNumber=59, createdTime=2021-08-03, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=920821494873, moduleTitle=Nat Med：靶向CD19和CD22的双特异性CAR-T疗法可治疗复发性/难治性B细胞恶性肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=920821494873)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899547, encodeId=34e0189954e54, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=ARD：肥胖对遗传易感人群中女性痛风风险的影响：超过 32 年的性别特异性前瞻性队列研究结果, objectType=article, longId=301218, objectId=9caf30121831, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9caf30121831, replyNumber=0, likeNumber=71, createdTime=2022-07-15, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9caf30121831, moduleTitle=ARD：肥胖对遗传易感人群中女性痛风风险的影响：超过 32 年的性别特异性前瞻性队列研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9caf30121831)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899526, encodeId=27a6189952617, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Clin Cancer Res：HER2双特异性抗体KN026单药治疗HER2+转移性乳腺癌的临床试验结果, objectType=article, longId=221530, objectId=eb62221530ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb62221530ea, replyNumber=0, likeNumber=70, createdTime=2022-06-08, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb62221530ea, moduleTitle=Clin Cancer Res：HER2双特异性抗体KN026单药治疗HER2+转移性乳腺癌的临床试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb62221530ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899520, encodeId=012618995208a, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Eur Respir J：新冠病毒和流感病毒感染的特异性宿主反应与基因特征, objectType=article, longId=219427, objectId=2c9521942ed5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c9521942ed5, replyNumber=0, likeNumber=63, createdTime=2021-12-01, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c9521942ed5, moduleTitle=Eur Respir J：新冠病毒和流感病毒感染的特异性宿主反应与基因特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c9521942ed5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899538, encodeId=be6d18995389f, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=2022年1月28日简报：杭州两天累计确诊14例本土奥密克戎病例，可能已有三代病例传播；Moderna、辉瑞宣布启动奥密克戎特异性COVID疫苗试验, objectType=article, longId=294844, objectId=144e294844cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=144e294844cc, replyNumber=0, likeNumber=76, createdTime=2022-07-17, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=144e294844cc, moduleTitle=2022年1月28日简报：杭州两天累计确诊14例本土奥密克戎病例，可能已有三代病例传播；Moderna、辉瑞宣布启动奥密克戎特异性COVID疫苗试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=144e294844cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899490, encodeId=da1c1899490ac, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Nat Commun：特异性拮抗Y1R可预防饮食引起的肥胖, objectType=article, longId=212432, objectId=f20221243213, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f20221243213, replyNumber=0, likeNumber=81, createdTime=2021-07-06, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f20221243213, moduleTitle=Nat Commun：特异性拮抗Y1R可预防饮食引起的肥胖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f20221243213)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899497, encodeId=bd03189949ea5, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=罗氏PD-1/LAG-3双特异性抗体在中国申报临床，有望用于转移性黑色素瘤、非小细胞肺癌、食管鳞状细胞癌、晚期肝癌多种适应症治疗, objectType=article, longId=213744, objectId=3257213e448e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3257213e448e, replyNumber=0, likeNumber=88, createdTime=2022-02-02, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3257213e448e, moduleTitle=罗氏PD-1/LAG-3双特异性抗体在中国申报临床，有望用于转移性黑色素瘤、非小细胞肺癌、食管鳞状细胞癌、晚期肝癌多种适应症治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3257213e448e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899500, encodeId=6bcb1899500cc, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Trials：手法治疗vs治疗性运动治疗非特异性慢性颈痛的疗效, objectType=article, longId=214006, objectId=369021400609, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=369021400609, replyNumber=0, likeNumber=53, createdTime=2022-02-22, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=369021400609, moduleTitle=Trials：手法治疗vs治疗性运动治疗非特异性慢性颈痛的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=369021400609)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899532, encodeId=aef918995324a, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=European Radiology：小儿急性阑尾炎的特异性MRI表现, objectType=article, longId=293012, objectId=43cf2930121b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43cf2930121b, replyNumber=0, likeNumber=77, createdTime=2022-07-25, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43cf2930121b, moduleTitle=European Radiology：小儿急性阑尾炎的特异性MRI表现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43cf2930121b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899492, encodeId=bfdb189949293, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=BMC Cancer：按膀胱癌阶段划分的癌症特异性生存以及与生存有关的因素 , objectType=article, longId=213084, objectId=223721308487, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=223721308487, replyNumber=0, likeNumber=89, createdTime=2021-07-26, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=223721308487, moduleTitle=BMC Cancer：按膀胱癌阶段划分的癌症特异性生存以及与生存有关的因素 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=223721308487)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899544, encodeId=4294189954445, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Cell Research：秦成峰团队发布Omicron特异性mRNA疫苗动物实验数据, objectType=article, longId=299275, objectId=50442992e540, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50442992e540, replyNumber=0, likeNumber=0, createdTime=2022-10-22, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50442992e540, moduleTitle=Cell Research：秦成峰团队发布Omicron特异性mRNA疫苗动物实验数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50442992e540)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899513, encodeId=03f518995136c, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=双特异性抗体——别出“新”裁的下一代免疫治疗, objectType=article, longId=216533, objectId=b436216533d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b436216533d1, replyNumber=0, likeNumber=60, createdTime=2021-09-24, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b436216533d1, moduleTitle=双特异性抗体——别出“新”裁的下一代免疫治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b436216533d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899499, encodeId=ecb2189949945, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=基石药业三特异性抗体CS2006/NM21-1480中国临床试验申请获受理，深度剖析到底有啥优势？, objectType=article, longId=213913, objectId=9af121391339, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9af121391339, replyNumber=0, likeNumber=43, createdTime=2021-12-08, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9af121391339, moduleTitle=基石药业三特异性抗体CS2006/NM21-1480中国临床试验申请获受理，深度剖析到底有啥优势？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9af121391339)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899533, encodeId=716e1899533e1, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=LEO Pharma宣布FDA核准Adbry™ (tralokinumab)作为特异性靶向作用于中度至重度特应性皮炎成人IL-13的治疗药物, objectType=article, longId=293187, objectId=acae29318e52, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=acae29318e52, replyNumber=0, likeNumber=85, createdTime=2022-01-27, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=acae29318e52, moduleTitle=LEO Pharma宣布FDA核准Adbry™ (tralokinumab)作为特异性靶向作用于中度至重度特应性皮炎成人IL-13的治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=acae29318e52)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899495, encodeId=1c4f1899495c6, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=柳叶刀揭示西班牙疫苗混打AZ疫苗与辉瑞疫苗后特异性抗体显著增高, objectType=article, longId=213406, objectId=1ca2213406cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ca2213406cb, replyNumber=0, likeNumber=75, createdTime=2021-10-25, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ca2213406cb, moduleTitle=柳叶刀揭示西班牙疫苗混打AZ疫苗与辉瑞疫苗后特异性抗体显著增高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ca2213406cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899478, encodeId=eef318994e858, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=J Allergy Clin Immunol：猫尾草皮下和舌下免疫疗法对过敏原特异性IgA反应的不同诱导作用, objectType=article, longId=210436, objectId=56fe21043635, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56fe21043635, replyNumber=0, likeNumber=105, createdTime=2022-01-20, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56fe21043635, moduleTitle=J Allergy Clin Immunol：猫尾草皮下和舌下免疫疗法对过敏原特异性IgA反应的不同诱导作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56fe21043635)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899521, encodeId=5ff1189952101, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=ARD：单细胞转录组分析可识别系统性硬化症中的皮肤特异性T细胞反应, objectType=article, longId=219890, objectId=ae67219890fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae67219890fc, replyNumber=0, likeNumber=85, createdTime=2022-06-14, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae67219890fc, moduleTitle=ARD：单细胞转录组分析可识别系统性硬化症中的皮肤特异性T细胞反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae67219890fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899535, encodeId=d74b189953531, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Am J Rhinol Allergy：鼻一氧化氮和鼻细胞学是否可作为舌下过敏原特异性免疫治疗短期疗效的预测标志物？, objectType=article, longId=293958, objectId=c76a29395823, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c76a29395823, replyNumber=0, likeNumber=90, createdTime=2022-04-16, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c76a29395823, moduleTitle=Am J Rhinol Allergy：鼻一氧化氮和鼻细胞学是否可作为舌下过敏原特异性免疫治疗短期疗效的预测标志物？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c76a29395823)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899503, encodeId=0f3f18995035c, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=J Eur Acad Dermatol Venereol：参与治疗性患者教育的特异性皮炎的患儿特征, objectType=article, longId=214464, objectId=f9c32144640d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9c32144640d, replyNumber=0, likeNumber=62, createdTime=2022-05-13, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9c32144640d, moduleTitle=J Eur Acad Dermatol Venereol：参与治疗性患者教育的特异性皮炎的患儿特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9c32144640d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

特异性

2020-05-29

jinweidong (审核中...)

前往app查看评论内容

#特异性#

双特异性抗体中CrossMab技术：过去的10年

2022-11-15

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Nat Med：靶向CD19和CD22的双特异性CAR-T疗法可治疗复发性/难治性B细胞恶性肿瘤

2021-08-03

仁医06 (审核中...)

前往app查看评论内容

#特异性#

ARD：肥胖对遗传易感人群中女性痛风风险的影响：超过 32 年的性别特异性前瞻性队列研究结果

2022-07-15

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Clin Cancer Res：HER2双特异性抗体KN026单药治疗HER2+转移性乳腺癌的临床试验结果

2022-06-08

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Eur Respir J：新冠病毒和流感病毒感染的特异性宿主反应与基因特征

2021-12-01

jinweidong (审核中...)

前往app查看评论内容

#特异性#

2022年1月28日简报：杭州两天累计确诊14例本土奥密克戎病例，可能已有三代病例传播；Moderna、辉瑞宣布启动奥密克戎特异性COVID疫苗试验

2022-07-17

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Nat Commun：特异性拮抗Y1R可预防饮食引起的肥胖

2021-07-06

jinweidong (审核中...)

前往app查看评论内容

#特异性#

罗氏PD-1/LAG-3双特异性抗体在中国申报临床，有望用于转移性黑色素瘤、非小细胞肺癌、食管鳞状细胞癌、晚期肝癌多种适应症治疗

2022-02-02

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Trials：手法治疗vs治疗性运动治疗非特异性慢性颈痛的疗效

2022-02-22

jinweidong (审核中...)

前往app查看评论内容

#特异性#

European Radiology：小儿急性阑尾炎的特异性MRI表现

2022-07-25

jinweidong (审核中...)

前往app查看评论内容

#特异性#

BMC Cancer：按膀胱癌阶段划分的癌症特异性生存以及与生存有关的因素

2021-07-26

仁医06 (审核中...)

前往app查看评论内容

#特异性#

Cell Research：秦成峰团队发布Omicron特异性mRNA疫苗动物实验数据

2022-10-22

jinweidong (审核中...)

前往app查看评论内容

#特异性#

双特异性抗体——别出“新”裁的下一代免疫治疗

2021-09-24

jinweidong (审核中...)

前往app查看评论内容

#特异性#

基石药业三特异性抗体CS2006/NM21-1480中国临床试验申请获受理，深度剖析到底有啥优势？

2021-12-08

jinweidong (审核中...)

前往app查看评论内容

#特异性#

LEO Pharma宣布FDA核准Adbry™ (tralokinumab)作为特异性靶向作用于中度至重度特应性皮炎成人IL-13的治疗药物

2022-01-27

jinweidong (审核中...)

前往app查看评论内容

#特异性#

柳叶刀揭示西班牙疫苗混打AZ疫苗与辉瑞疫苗后特异性抗体显著增高

2021-10-25

jinweidong (审核中...)

前往app查看评论内容

#特异性#

J Allergy Clin Immunol：猫尾草皮下和舌下免疫疗法对过敏原特异性IgA反应的不同诱导作用

2022-01-20

jinweidong (审核中...)

前往app查看评论内容

#特异性#

ARD：单细胞转录组分析可识别系统性硬化症中的皮肤特异性T细胞反应

2022-06-14

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Am J Rhinol Allergy：鼻一氧化氮和鼻细胞学是否可作为舌下过敏原特异性免疫治疗短期疗效的预测标志物？

2022-04-16

jinweidong (审核中...)

前往app查看评论内容

#特异性#

J Eur Acad Dermatol Venereol：参与治疗性患者教育的特异性皮炎的患儿特征

2022-05-13

科室
- - 订阅+
  - 更多科室
工具
服务